Withdrawal of Registration Statement (rw)
02 Agosto 2016 - 5:07PM
Edgar (US Regulatory)
Bioventus Inc.
4721 Emperor Boulevard, Suite 100
Durham, North Carolina 27703
(919) 474-6700
August 2, 2016
VIA EDGAR
United States Securities and Exchange
Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Amanda Ravitz and
Caleb French
|
|
Request to Withdraw Registration Statement on Form S-1
|
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended (the
Securities Act
), Bioventus Inc. (the
Company
)
hereby requests that, effective as of the date hereof or at the earliest practicable date hereafter, the Securities and Exchange Commission (the
Commission
) consent to the withdrawal of the Companys Registration Statement on
Form S-1 (File No. 333-212329), together with all amendments and exhibits thereto (collectively, the
Form S-1
). The Form S-1 originally was submitted confidentially to the Commission on April 19, 2016 and initially was
filed on June 30, 2016.
The Company submits this request for withdrawal as it does not intend to pursue the contemplated public offering of the
securities covered by the Form S-1 at this time. The Company confirms that the Form S-1 has not been declared effective, no securities have been or will be issued or sold pursuant to the Form S-1 or the prospectus contained therein.
The Company further requests that, in accordance with Rule 457(p) of the Securities Act, all fees paid to the Commission in connection with the filing of the
Form S-1 be credited for future use.
In addition, the Company requests that the Commission consent to the withdrawal of the Companys Registration
Statement on Form 8-A (File No. 001-37844), originally filed with the Commission on July 26, 2016, effective as of the date hereof or at the earliest practicable date hereafter.
The Company may undertake a subsequent private offering in reliance on Rule 155(c) promulgated under the Securities Act.
Please send copies of the written order granting withdrawal of the Form S-1 and Form 8-A to the undersigned at Bioventus Inc., 4721 Emperor Boulevard, Suite
100, Durham, North Carolina 27703, with a copy to Companys counsel, Latham & Watkins LLP, 885 Third Avenue, New York, New York 10022, attention Wesley C. Holmes.
If you have any questions or require any further information, please contact Wesley C. Holmes at (212) 906-1366.
|
|
|
Respectfully submitted,
|
|
Bioventus Inc.
|
|
|
By:
|
|
/s/ Anthony P. Bihl III
|
|
|
Name: Anthony P. Bihl III
Title:
Chief Executive Officer
|
cc:
|
David J. Price, Bioventus Inc.
|
|
Jeanne M. Forneris, Esq., Bioventus Inc.
|
|
Charles K. Ruck, Latham & Watkins LLP
|
BIOVENTUS INC. (NASDAQ:BIOV)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
BIOVENTUS INC. (NASDAQ:BIOV)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024